FDA.reportPublic FDA data

relugolix 120 MG Oral Tablet [Orgovyx]

RxCUI
2472789
RxNorm name
relugolix 120 MG Oral Tablet [Orgovyx]
Display name
relugolix 120 MG Oral Tablet [Orgovyx]
Full name
relugolix 120 MG Oral Tablet [Orgovyx]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
077a92f6-9f1b-479a-87c7-c92b5db6aa9cORGOVYX 120 MG Oral Tablet [PSN] · relugolix 120 MG Oral Tablet [Orgovyx] [SBD] · Orgovyx 120 MG Oral Tablet [SY]312These highlights do not include all the information needed to use ORGOVYX safely and effectively. See full prescribing information for ORGOVYX. ORGOVYX (relugolix) tablets, for oral use Initial U.S. Approval: 202020251010